| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/21/2006 | EP1670505A2 Dna promoters and anthrax vaccines |
| 06/21/2006 | EP1670504A1 Vaccines containingthe hiv tat protein as an adjuvant for the enhancement of cytotoxic t-cell responses |
| 06/21/2006 | EP1670503A1 Immunotherapy method |
| 06/21/2006 | EP1670500A2 Compositions capable of facilitating penetration across a biological barrier |
| 06/21/2006 | EP1670499A2 Methods for treating cardiovascular disease using a soluble ctla4 molecule |
| 06/21/2006 | EP1345624B1 Induction of tolerance |
| 06/21/2006 | EP1343526B1 Vaccine for the treatment of nicotine addiction |
| 06/21/2006 | EP1305041B1 Medicament for the immunotherapy of malignant tumours |
| 06/21/2006 | EP1192185B1 Apo-2L RECEPTOR AGONIST AND CPT-11 SYNERGISM |
| 06/21/2006 | EP1140170B1 Antibody fragments for the topical treatment of ocular diseases |
| 06/21/2006 | EP1042363B1 Novel anti-hiv immunogens (toxoids), preparation methods and use for preventing and treating aids |
| 06/21/2006 | EP1007089B1 Anticoagulant humanised antibodies against factor IX, for use in the treatment of thrombosis |
| 06/21/2006 | EP0998941B1 Use of midkine or of anti-midkine antibodies |
| 06/21/2006 | EP0934416B1 Feline polynucleotide vaccine formula |
| 06/21/2006 | EP0932626B1 G protein-coupled receptor antagonists |
| 06/21/2006 | EP0912198B1 Immunoliposomes that optimize internalization into target cells |
| 06/21/2006 | EP0830456B1 ISOLATED FrpB NUCLEIC ACID MOLECULE AND VACCINE |
| 06/21/2006 | EP0811384B1 Muscle protein decomposition inhibitor containing il-6 receptor antibody |
| 06/21/2006 | EP0778888B1 Antigenically-marked non-infectious retrovirus-like particles |
| 06/21/2006 | EP0754231B1 Peptide fragment of the respiratory syncytial virus g protein, immunogenic agent, pharmaceutical composition containing same, and preparation method |
| 06/21/2006 | CN1791614A Construct comprising recognition domain of antibody against von Willebrand factor-specific cleaving enzyme |
| 06/21/2006 | CN1791433A DNA vaccines against tumor growth and methods of use thereof |
| 06/21/2006 | CN1791432A Vaccine composition comprising iron phosphate as a pharmaceutical aid to said vaccine |
| 06/21/2006 | CN1791427A Method and composition of a novel vaccine design for the prevention and treatment of SARS |
| 06/21/2006 | CN1791426A Inactivated vibrio cholerae vaccine in tablet form |
| 06/21/2006 | CN1789410A Low toxic bacterial strain of Pasteurella multocid B26-T1200 |
| 06/21/2006 | CN1260360C Lipid kinase |
| 06/21/2006 | CN1260357C Improved anti-IgE antibodies and method of improving polypeptides |
| 06/21/2006 | CN1259973C Preventives or remedies for psoriasis containing IL-6 antagonist as the active ingredient |
| 06/21/2006 | CN1259972C Anticoagulant agent and humanized anti-von willebrand factor monoclonal antibody |
| 06/21/2006 | CN1259910C Liquid drug preparations |
| 06/21/2006 | CN1259901C Musk liposome injection and its preparation method |
| 06/20/2006 | USRE39138 antibodies used in enzyme-linked immunosorbent assays for detection of low density lipoproteins, immunoglobulins, collagen, serum and urinary peptides or proteins |
| 06/20/2006 | US7064244 Transgenic mammals having human Ig loci including plural VH and VK regions and antibodies produced therefrom |
| 06/20/2006 | US7064195 Fusion proteins of mycobacterium tuberculosis antigens and their uses |
| 06/20/2006 | US7064190 An isolated complex of a peptide of glutamic acid decarboxylase(with specific 6 contiguous amino acids), and an allele of MHC class II molecules DR3 and DR4; useful for diagnosis and therapy of autoimmune diseases |
| 06/20/2006 | US7064189 Antibodies that immunospecifically bind to trail receptors |
| 06/20/2006 | US7064186 Comprises chemokine polypeptides for diagnosis, prevention and treatment of cell proliferative, immunological and hematopoietic disorders |
| 06/20/2006 | US7064185 Antibody for human Cyr61 |
| 06/20/2006 | US7064111 activating or enhancing T-cell response by locally administering a herpes simplex virus vector with an expressible nucleotide sequence for the soluble costimulatory factor B7-1-Ig or B7-2-Ig, so that the factor is expressed by tumor cells or cells in the immediate area of the tumor |
| 06/20/2006 | US7063964 Nucleic acids encoding IL-12 antibody |
| 06/20/2006 | US7063963 Nucleotide sequences consisiting of DNA viral open reading frames which code proteins which can be used to prepare genetic vaccines which prevent viral diseases |
| 06/20/2006 | US7063960 Interacting the immature dendritic cels with an antigen ex vivo so that the surface antigen is presented; inducing maturation ex vivo; and contacting with a modulator comprising TRANCE or derivative |
| 06/20/2006 | US7063954 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 06/20/2006 | US7063949 Methods for isolating molecular mimetics of unique Neisseria meningitidis serogroup B epitopes |
| 06/20/2006 | US7063854 Polypeptide comprising the immunogenic portion of wilms' tumor suppressor gene(wt1); tumor-associated antigen for use in cancer immunotherapy |
| 06/20/2006 | US7063853 DNA immunization against Chlamydia infection |
| 06/20/2006 | US7063852 Hybrid LT-A/CT-B holotoxin for use as an adjuvant |
| 06/20/2006 | US7063851 Herpes viruses for immune modulation |
| 06/20/2006 | US7063850 Protective antigen of group A Streptococci |
| 06/20/2006 | US7063849 Use of HIV-1 gp120 and gp160 proteins modified in the v3 loop for the preparation of vaccine compositions and formulations containing the same |
| 06/20/2006 | US7063848 Lipoglycan compositions and methods of treating parasitic infections |
| 06/20/2006 | US7063847 Compositions and methods for enhancing immune responses mediated by antigen-presenting cells |
| 06/20/2006 | US7063846 Purified or isolated antibody that binds to said outer membrane proteins; accurate diagnosis of ehrlichiosis |
| 06/20/2006 | US7063845 Human anti-CD40 antibodies |
| 06/20/2006 | US7063844 Presentation of hydrophobic antigens to T-cells by CD1 molecules |
| 06/20/2006 | US7063843 Cloning and regulation of an endothelial cell protein C/activated protein C receptor |
| 06/20/2006 | US7063842 Compounds and methods for inhibiting the interaction between α-catenin and β-catenin |
| 06/20/2006 | US7063841 Mammalian cell surface antigens; related reagents |
| 06/20/2006 | US7063840 Genes for receptor tyrosine kinases and their cognate ligands, their insertion into genetic engineered DNA vectors; useful in the diagnosis and treatment of neoplastic diseases |
| 06/20/2006 | US7063835 Virus strains |
| 06/20/2006 | CA2127700C Marek's disease virus recombinant poxvirus vaccine |
| 06/15/2006 | WO2006063329A2 Enhanced protection against mycobacterium tuberculosis |
| 06/15/2006 | WO2006063164A2 Compositions and methods for treating neuroendocrine tumors |
| 06/15/2006 | WO2006063152A2 Immunostimulatory combinations and methods |
| 06/15/2006 | WO2006063150A2 Methods and compositions for immunotherapy and detection of inflammatory and immune-dysregulatory disease, infectious disease, pathologic angiogenesis and cancer |
| 06/15/2006 | WO2006063101A2 Vaccines for the rapid response to pandemic avian influenza |
| 06/15/2006 | WO2006063072A2 Immunomodulatory compositions, combinations and methods |
| 06/15/2006 | WO2006063053A2 Methods of producing influenza vaccine compositions |
| 06/15/2006 | WO2006062917A2 Alpha thymosin peptides as cancer vaccine adjuvants |
| 06/15/2006 | WO2006062807A2 Compositions with enhanced immunogenicity |
| 06/15/2006 | WO2006062779A2 Anti-integrin immunoconjugates, methods and uses |
| 06/15/2006 | WO2006062637A2 Influenza vaccination |
| 06/15/2006 | WO2006062266A1 Genes of a korean isolate rbiv and a vaccine against rbiv |
| 06/15/2006 | WO2006062094A1 Novel cancer antigen peptide and the use thereof |
| 06/15/2006 | WO2006061643A1 Method for vaccinating usign a prime-boost regime and hsv as a vector |
| 06/15/2006 | WO2006061253A2 Combination of tyrosine kinase inhibitor and her-2/neu for cancer therapy |
| 06/15/2006 | WO2006060969A1 Peptides which mimic the antigenic regions of the hepatitis a virus |
| 06/15/2006 | WO2006060903A1 Signal peptides, nucleic acid molecules and methods of treatment |
| 06/15/2006 | WO2006060878A1 Methods and compositions for adoptive immunotherapy |
| 06/15/2006 | WO2006050341A3 Modified streptococcal polysaccharides and uses thereof |
| 06/15/2006 | WO2006039045A3 Adenoviral vectors able to transduce apcs, potential use in immune response generation |
| 06/15/2006 | WO2006033672A3 Immunization regimen with e4-deleted adenovirus prime and e1-deleted adenovirus boost |
| 06/15/2006 | WO2006027584A3 Vaccines against neisseria |
| 06/15/2006 | WO2006024367A3 Use of nkg2d receptor/nkg2d ligand interaction blockers in the treatment of auto-immune diseases |
| 06/15/2006 | WO2006013013A3 Diagnostics and therapeutics for diseases associated with protective protein for beta-galactosidase (ppgb) |
| 06/15/2006 | WO2006009862A3 Amebiasis subunit vaccine |
| 06/15/2006 | WO2006004663A3 Increasing the production of recombinant antibodies in mammalian cells by site-directed mutagenesis |
| 06/15/2006 | WO2005123923A3 Inducer specific tetracycline repressor proteins and methods of use thereof |
| 06/15/2006 | WO2005123121A3 Use of dna molecule as vaccine adjuvant |
| 06/15/2006 | WO2005117986A3 Antibody drug conjugates and methods |
| 06/15/2006 | WO2005115448A8 Multi plasmid system for the production of influenza virus |
| 06/15/2006 | WO2005110436A3 Macromolecule-containing sustained release intraocular implants and related methods |
| 06/15/2006 | WO2005099756A3 ErbB ANTAGONISTS FOR PAIN THERAPY |
| 06/15/2006 | WO2005092380A3 Uses of anti-ctla-4 antibodies |
| 06/15/2006 | WO2005086698A3 Methods for altering t cell diversity |
| 06/15/2006 | WO2005072777A3 Conjugates of amyloid proteins as vaccines for amyloid-related diseases |
| 06/15/2006 | WO2005065718A3 Antitumour treatments with metxia-p450 and cyclophosphamide or 5t4 vaccine |
| 06/15/2006 | WO2005007683A8 Antigen epitopes of the regulatory protein of virulence factor in staphylococcus aureus and their mimotopes and use |
| 06/15/2006 | WO2004094596A8 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |